104 related articles for article (PubMed ID: 8675981)
41. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
42. Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
Terada N; Shimizu Y; Yoshida T; Maeno A; Kamba T; Inoue T; Nakamura E; Kamoto T; Ogawa O
Prostate; 2010 Feb; 70(3):252-61. PubMed ID: 19790238
[TBL] [Abstract][Full Text] [Related]
43. [The antiandrogen treatment of patients with prostatic cancer and bone metastases].
Matveev BP; Bukharkin BV; Zhumagazin ZhD
Urol Nefrol (Mosk); 1993; (1):10-4. PubMed ID: 7941115
[TBL] [Abstract][Full Text] [Related]
44. Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.
Narimoto K; Mizokami A; Izumi K; Mihara S; Sawada K; Sugata T; Shimamura M; Miyazaki K; Nishino A; Namiki M
Int J Urol; 2010 Apr; 17(4):337-45. PubMed ID: 20202011
[TBL] [Abstract][Full Text] [Related]
45. Microscopic polyangiitis complicated by the development of prostate cancer and flutamide-induced hepatitis.
Papaioannides D; Korantzopoulos P; Bouropoulos C; Latsi P; Fotinou M; Orphanidou D
Int Urol Nephrol; 2005; 37(3):515-20. PubMed ID: 16307333
[TBL] [Abstract][Full Text] [Related]
46. [Hepatoxicity caused by flutamide increased by hypotensive situation?].
Serrano Hernández N; García López F; Fedriani Gorria J
An Med Interna; 1996 Nov; 13(11):552-4. PubMed ID: 9019217
[TBL] [Abstract][Full Text] [Related]
47. [Antiandrogen in prostate cancer].
Maeda O; Usami M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
[No Abstract] [Full Text] [Related]
48. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade.
Schellhammer PF; Venner P; Haas GP; Small EJ; Nieh PT; Seabaugh DR; Patterson AL; Klein E; Wajsman Z; Furr B; Chen Y; Kolvenbag GJ
J Urol; 1997 May; 157(5):1731-5. PubMed ID: 9112515
[TBL] [Abstract][Full Text] [Related]
49. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
50. [Experience with therapy of prostate cancer in the Primorye Territory].
Gurina LI; Iudin SV
Vopr Onkol; 2004; 50(5):599-601. PubMed ID: 15715105
[TBL] [Abstract][Full Text] [Related]
51. [The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma].
Kliesch S; Behre HM; Roth S
Dtsch Med Wochenschr; 1997 Jul; 122(30):940-5. PubMed ID: 9280708
[No Abstract] [Full Text] [Related]
52. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
Patel H; Rhee E; Zimmern PE
J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
[TBL] [Abstract][Full Text] [Related]
53. [Fluamide withdrawal syndrome].
Morote J; Lorente JA; Vallejo C
Actas Urol Esp; 1994 Jun; 18(6):681-2. PubMed ID: 7942220
[No Abstract] [Full Text] [Related]
54. Flutamide-associated acute liver failure.
Famularo G; De Simone C; Minisola G; Nicotra GC
Ann Ital Med Int; 2003; 18(4):250-3. PubMed ID: 14971714
[TBL] [Abstract][Full Text] [Related]
55. [Antiandrogen withdrawal syndrome].
Akimoto S
Nihon Rinsho; 1998 Aug; 56(8):2135-9. PubMed ID: 9750522
[TBL] [Abstract][Full Text] [Related]
56. Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2).
Chime-Udeh E
Conn Med; 1991 Sep; 55(9):526-8. PubMed ID: 1748007
[No Abstract] [Full Text] [Related]
57. Newer methods of hormonal therapy for prostate cancer.
Soloway MS
Urology; 1984 Nov; 24(5 Suppl):30-8. PubMed ID: 6437034
[TBL] [Abstract][Full Text] [Related]
58. [Hepatotoxicity from flutamide].
Cantalejo Moreira M; García Espinosa V; Martín Gutiérrez JC; García Puig J
Med Clin (Barc); 1997 Dec; 109(20):819-20. PubMed ID: 9493165
[No Abstract] [Full Text] [Related]
59. [Acute flutamide-induced hepatitis].
Nicolás D; Pérez-EbrI ML; Sarrión JV; Nos P
Gastroenterol Hepatol; 1999 May; 22(5):262-3. PubMed ID: 10396113
[No Abstract] [Full Text] [Related]
60. The treatment of chyluria secondary to advanced carcinoma of the prostate.
Cluskey SA; Myatt A; Ferro MA
Prostate Cancer Prostatic Dis; 2008; 11(1):102-5. PubMed ID: 17667966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
